There are 3164 resources available
1401O - Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03)
Presenter: Yelena Janjigian
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Abstract
Slides
Webcast
LBA55 - Mechanisms of acquired resistance to first-line amivantamab plus lazertinib versus osimertinib in patients with EGFR-mutant advanced non-small cell lung cancer: An early analysis from the phase III MARIPOSA study
Presenter: Benjamin Besse
Session: Proffered paper session: NSCLC metastatic
Resources:
Abstract
Slides
Webcast
Lifetime Achievement Award, RECaN Award, NRDA Award
Session: EONS17 Opening session and Keynote lecture
Resources:
Slides
Webcast
Q&A and discussion
Session: Precision medicine in NEN: Where we are
Resources:
Webcast
Q&A and discussion
Session: Gynaecological cancer: How can technology help the fight?
Resources:
Webcast
Q&A and discussion
Session: Hot topics in sarcoma
Resources:
Webcast
852MO - REWRITE–GORTEC 2018-02: Radiotherapy-durvalumab without prophylactic neck irradiation in squamous cell carcinoma of the head and neck
Presenter: Joël Castelli
Session: Mini oral session: Head and neck cancer
Resources:
Abstract
Slides
Webcast
1253O - Phase I/II ALKOVE-1 study of NVL-655 in ALK-positive (ALK+) solid tumours
Presenter: Alexander Drilon
Session: Proffered paper session: NSCLC metastatic
Resources:
Abstract
Slides
Webcast
Conclusions and perspectives
Presenter: Marco Volante
Session: Precision medicine in NEN: Where we are
Resources:
Slides
Webcast
Invited Discussant 1400O and 1401O
Presenter: Filippo Pietrantonio
Session: Proffered paper session 2: GI tumours, upper digestive
Resources:
Slides
Webcast